875148-45-1 Usage
Description
Lexiscan, also known as regadenoson, is a prescription medication that functions as a pharmacologic stress agent for myocardial perfusion imaging. It is specifically designed for patients who cannot exercise adequately. Lexiscan operates by increasing blood flow to the heart, which assists healthcare providers in assessing the presence of coronary artery disease. Administered as an intravenous injection, Lexiscan stimulates adenosine receptors in the body, leading to the dilation of coronary arteries.
Uses
Used in Cardiology:
Lexiscan is used as a diagnostic tool for evaluating the presence of coronary artery disease in patients who are unable to undergo exercise stress testing. It is used for:
1. Myocardial Perfusion Imaging: Lexiscan is used as a pharmacologic stress agent for myocardial perfusion imaging to help healthcare providers detect and diagnose coronary artery disease by increasing blood flow to the heart.
2. Adenosine Receptor Stimulation: Lexiscan is used to stimulate adenosine receptors in the body, which results in the dilation of coronary arteries, providing a clearer view of blood flow and blockages within the heart.
Common side effects associated with Lexiscan may include flushing, chest discomfort, shortness of breath, dizziness, and headache. It is crucial for patients to inform their healthcare providers about any pre-existing heart conditions, asthma, or other lung diseases before receiving Lexiscan treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 875148-45-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,5,1,4 and 8 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 875148-45:
(8*8)+(7*7)+(6*5)+(5*1)+(4*4)+(3*8)+(2*4)+(1*5)=201
201 % 10 = 1
So 875148-45-1 is a valid CAS Registry Number.
875148-45-1Relevant articles and documents
PROCESS FOR PREPARING AN A2A-ADENOSINE RECEPTOR AGONIST AND ITS POLYMORPHS
-
, (2009/01/20)
Disclosed is a synthesis suitable for large scale manufacture of an A2A-adenosine receptor agonist, and also relates to polymorphs of that compound, and to methods of isolating a specific polymorph.
